Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
Type 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vascul...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/18 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832589039403794432 |
---|---|
author | John Dawi Yura Misakyan Stephen Affa Samuel Kades Ananya Narasimhan Fouad Hajjar Max Besser Kevin Tumanyan Vishwanath Venketaraman |
author_facet | John Dawi Yura Misakyan Stephen Affa Samuel Kades Ananya Narasimhan Fouad Hajjar Max Besser Kevin Tumanyan Vishwanath Venketaraman |
author_sort | John Dawi |
collection | DOAJ |
description | Type 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vasculature and nervous system. Glutathione (GSH), a major antioxidant, is crucial for neutralizing ROS, but GSH levels are notably low in T2DM, exacerbating oxidative stress and inflammation. Elevated interleukin-6 (IL-6) levels further intensify inflammation and oxidative stress, disrupting insulin signaling and worsening complications such as nephropathy, retinopathy, and neuropathy. While lifestyle modifications and antioxidant supplementation are current approaches for managing oxidative stress, their effectiveness in preventing complications remains under study. Recent investigations suggest that GSH and Vitamin D3 supplementation may offer dual-action benefits, as Vitamin D3 not only has anti-inflammatory properties but also promotes GSH synthesis. This dual action helps mitigate both oxidative stress and inflammation, addressing key pathological features of T2DM. This review highlights the complex interactions between oxidative stress, GSH insufficiency, and IL-6, and emphasizes the potential of targeted therapies to improve the management and outcomes of T2DM. |
format | Article |
id | doaj-art-48257f96c5da4f76b88dbd86e41cae43 |
institution | Kabale University |
issn | 2227-9059 |
language | English |
publishDate | 2024-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj-art-48257f96c5da4f76b88dbd86e41cae432025-01-24T13:23:44ZengMDPI AGBiomedicines2227-90592024-12-011311810.3390/biomedicines13010018Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic InterventionsJohn Dawi0Yura Misakyan1Stephen Affa2Samuel Kades3Ananya Narasimhan4Fouad Hajjar5Max Besser6Kevin Tumanyan7Vishwanath Venketaraman8College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USADepartment of Chemistry, Physics, and Engineering, Los Angeles Valley College, Valley Glen, CA 91401, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Podiatric Medicine, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USAType 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vasculature and nervous system. Glutathione (GSH), a major antioxidant, is crucial for neutralizing ROS, but GSH levels are notably low in T2DM, exacerbating oxidative stress and inflammation. Elevated interleukin-6 (IL-6) levels further intensify inflammation and oxidative stress, disrupting insulin signaling and worsening complications such as nephropathy, retinopathy, and neuropathy. While lifestyle modifications and antioxidant supplementation are current approaches for managing oxidative stress, their effectiveness in preventing complications remains under study. Recent investigations suggest that GSH and Vitamin D3 supplementation may offer dual-action benefits, as Vitamin D3 not only has anti-inflammatory properties but also promotes GSH synthesis. This dual action helps mitigate both oxidative stress and inflammation, addressing key pathological features of T2DM. This review highlights the complex interactions between oxidative stress, GSH insufficiency, and IL-6, and emphasizes the potential of targeted therapies to improve the management and outcomes of T2DM.https://www.mdpi.com/2227-9059/13/1/18T2DMGSHROSVitamin D3IL-6β-cells |
spellingShingle | John Dawi Yura Misakyan Stephen Affa Samuel Kades Ananya Narasimhan Fouad Hajjar Max Besser Kevin Tumanyan Vishwanath Venketaraman Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions Biomedicines T2DM GSH ROS Vitamin D3 IL-6 β-cells |
title | Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions |
title_full | Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions |
title_fullStr | Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions |
title_full_unstemmed | Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions |
title_short | Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions |
title_sort | oxidative stress glutathione insufficiency and inflammatory pathways in type 2 diabetes mellitus implications for therapeutic interventions |
topic | T2DM GSH ROS Vitamin D3 IL-6 β-cells |
url | https://www.mdpi.com/2227-9059/13/1/18 |
work_keys_str_mv | AT johndawi oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT yuramisakyan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT stephenaffa oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT samuelkades oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT ananyanarasimhan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT fouadhajjar oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT maxbesser oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT kevintumanyan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions AT vishwanathvenketaraman oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions |